It is not approved by the FDA for any medical application and is not intended for human or veterinary use
BPC-157 is a synthetic 15 amino acid peptide derived from a gastric protective protein fragment, while TB-500 refers to a thymosin beta 4 fragment commonly studied in peptide research
After the meeting, the FDA will review the votes, discussion and public comments before making a decision on each of the peptides
Unlike conventional treatments like NSAIDs (which reduce pain temporarily) or corticosteroid injections (which can weaken tissue over time), BPC-157 actually promotes regeneration of damaged tissues
This information is for educational purposes and does not replace medical advice
It's usually treated with B12 injections or high-dose oral supplements, dietary advice, and, in some cases, proton pump inhibitors to reduce stomach acid levels